Impact of palbociclib combinations on treatment of advanced estrogen receptor-positive/human epidermal growth factor 2-negative breast cancer

por Boér, Katalin
Publicado 2016

Fulvestrant in advanced breast cancer: evidence to date and place in therapy

por Boér, Katalin
Publicado 2017

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience

por Boér, Katalin, Rubovszky, Gábor, Rokszin, György, Abonyi-Tóth, Zsolt, Földesi, Csenge, Dank, Magdolna
Publicado 2021

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving...

por Boér, Katalin, Kahán, Zsuzsanna, Landherr, László, Csőszi, Tibor, Máhr, Károly, Ruzsa, Ágnes, Horváth, Zsolt, Budai, Barna, Rubovszky, Gábor
Publicado 2021

Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

por Rubovszky, Gábor, Kocsis, Judit, Boér, Katalin, Chilingirova, Nataliya, Dank, Magdolna, Kahán, Zsuzsanna, Kaidarova, Dilyara, Kövér, Erika, Krakovská, Bibiana Vertáková, Máhr, Károly, Mriňáková, Bela, Pikó, Béla, Božović-Spasojević, Ivana, Horváth, Zsolt
Publicado 2022

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer

por Rubovszky, Gábor, Kocsis, Judit, Boér, Katalin, Chilingirova, Nataliya, Dank, Magdolna, Kahán, Zsuzsanna, Kaidarova, Dilyara, Kövér, Erika, Krakovská, Bibiana Vertáková, Máhr, Károly, Mriňáková, Bela, Pikó, Béla, Božović-Spasojević, Ivana, Horváth, Zsolt
Publicado 2023

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast...

por Finn, Richard S., Boer, Katalin, Bondarenko, Igor, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu, Voitko, Nataliia, Bananis, Eustratios, McRoy, Lynn, Wilner, Keith, Huang, Xin, Kim, Sindy, Slamon, Dennis J., Ettl, Johannes
Publicado 2020

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from...

por Finn, Richard S., Crown, John P., Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M., Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T., Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J.
Publicado 2016

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

por Kiss, Zoltán, Kocsis, Judit, Nikolényi, Alíz, Horváth, Zsolt, Knollmajer, Kata, Benedek, Angéla, Várnai, Máté, Polányi, Zoltán, Kovács, Krisztina Andrea, Berta, Andrea, Köveskuti, István, Karamousouli, Eugenia, Szabó, Tamás Géza, Rokszin, György, Fábián, Ibolya, Bartókné Tamás, Renáta, Surján, Orsolya, Fürtős, Diána, Surján, György, Kenessey, István, Weber, András, Barcza, Zsófia, Berki, Tamás, Vokó, Zoltán, Dózsa, Csaba, Dank, Magdolna, Boér, Katalin
Publicado 2023